FdaApplication
ANDA 212512
Identifiers
- fda_app_no: ANDA212512
Properties
| Property | Value |
|---|---|
| applicant_name | BE PHARMACEUTICALS AG |
| application_type | ANDA |
| approval_date | 2019-05-13 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION;INTRAVENOUS |
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION;INTRAVENOUS |
2 products